Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1964 2
1967 2
1969 1
1970 1
1971 1
1972 1
1973 1
1974 3
1975 1
1976 1
1977 2
1978 3
1979 5
1980 5
1981 3
1982 3
1983 3
1984 7
1985 7
1986 2
1987 18
1988 26
1989 32
1990 36
1991 37
1992 50
1993 53
1994 61
1995 67
1996 71
1997 78
1998 85
1999 83
2000 110
2001 100
2002 127
2003 122
2004 189
2005 197
2006 230
2007 235
2008 283
2009 328
2010 351
2011 427
2012 387
2013 592
2014 1219
2015 1429
2016 1604
2017 1730
2018 1887
2019 1960
2020 2289
2021 2493
2022 2358
2023 2207
2024 891

Text availability

Article attribute

Article type

Publication date

Search Results

21,523 results

Results by year

Filters applied: . Clear all
Page 1
Management and Pharmacological Treatment of Peripheral Arterial Disease.
Leatham SJ, Winckel KR, De Guzman KR. Leatham SJ, et al. J Pharm Pract. 2024 May 1:8971900241250084. doi: 10.1177/08971900241250084. Online ahead of print. J Pharm Pract. 2024. PMID: 38693597 Review.
Peripheral arterial disease often co-exists with other vascular disease states, including cerebrovascular and cardiovascular disease. Optimal therapy for managing symptoms and progression of disease employs non-pharmacological, pharmacological, and contemporary revasculari …
Peripheral arterial disease often co-exists with other vascular disease states, including cerebrovascular and cardiovascular disease. …
Enablers and barriers to primary health care access for Indigenous adolescents: a systematic review and meta-aggregation of studies across Australia, Canada, New Zealand, and USA.
Harfield S, Purcell T, Schioldann E, Ward J, Pearson O, Azzopardi P. Harfield S, et al. BMC Health Serv Res. 2024 Apr 30;24(1):553. doi: 10.1186/s12913-024-10796-5. BMC Health Serv Res. 2024. PMID: 38693527
METHODS: We systematically searched databases for publications reporting enablers or barriers to primary health care access for Indigenous adolescents from the perspective of adolescents, their parents and health care providers, and included studies focused on Indigenous adolesce …
METHODS: We systematically searched databases for publications reporting enablers or barriers to primary health care access for Indigenous a …
Structural and molecular basis of choline uptake into the brain by FLVCR2.
Cater RJ, Mukherjee D, Gil-Iturbe E, Erramilli SK, Chen T, Koo K, Santander N, Reckers A, Kloss B, Gawda T, Choy BC, Zhang Z, Katewa A, Larpthaveesarp A, Huang EJ, Mooney SWJ, Clarke OB, Yee SW, Giacomini KM, Kossiakoff AA, Quick M, Arnold T, Mancia F. Cater RJ, et al. Nature. 2024 May 1. doi: 10.1038/s41586-024-07326-y. Online ahead of print. Nature. 2024. PMID: 38693257
We also determine the structures of choline-bound FLVCR2 in both inward-facing and outward-facing states using cryo-electron microscopy. These results reveal how the brain obtains choline and provide molecular-level insights into how FLVCR2 binds choline in an aromatic cag …
We also determine the structures of choline-bound FLVCR2 in both inward-facing and outward-facing states using cryo-electron microsco …
Recognising the importance and impact of Imaging Scientists: Global guidelines for establishing career paths within core facilities.
Wright GD, Thompson KA, Reis Y, Bischof J, Hockberger PE, Itano MS, Yen L, Adelodun ST, Bialy N, Brown CM, Chaabane L, Chew TL, Chitty AI, Cordelières FP, De Niz M, Ellenberg J, Engelbrecht L, Fabian-Morales E, Fazeli E, Fernandez-Rodriguez J, Ferrando-May E, Fletcher G, Galloway GJ, Guerrero A, Guimarães JM, Jacobs CA, Jayasinghe S, Kable E, Kitten GT, Komoto S, Ma X, Marques JA, Millis BA, Miranda K, JohnO'Toole P, Olatunji SY, Paina F, Pollak CN, Prats C, Pylvänäinen JW, Rahmoon MA, Reiche MA, Riches JD, Rossi AH, Salamero J, Thiriet C, Terjung S, Vasconcelos ADS, Keppler A. Wright GD, et al. J Microsc. 2024 May 1. doi: 10.1111/jmi.13307. Online ahead of print. J Microsc. 2024. PMID: 38691400
Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period.
Ward LM, Högler W, Glorieux FH, Portale AA, Whyte MP, Munns CF, Nilsson O, Simmons JH, Padidela R, Namba N, Cheong HI, Sochett E, Muroya K, Tanaka H, Pitukcheewanont P, Gottesman GS, Biggin A, Perwad F, Chen A, Lawrence Merritt Ii J, Imel EA. Ward LM, et al. JBMR Plus. 2024 Jan 4;8(1):ziad001. doi: 10.1093/jbmrpl/ziad001. eCollection 2024 Jan. JBMR Plus. 2024. PMID: 38690124 Free PMC article. Clinical Trial.
High prevalence of diabetes among young First Nations Peoples with metabolic dysfunction-associated steatotic liver disease: a population-based study in Australia.
Valery PC, Roche S, Brown C, O'Beirne J, Hartel G, Leggett B, Skoien R, Powell EE. Valery PC, et al. Int J Equity Health. 2024 Apr 30;23(1):84. doi: 10.1186/s12939-024-02153-z. Int J Equity Health. 2024. PMID: 38689295 Free article.
METHODS: A retrospective analysis of all adults hospitalized with MASLD or metabolic dysfunction-associated steatohepatitis (MASH) with/without cirrhosis during 2007-2019 in the state of Queensland was performed. Patients were followed from the first admission with …
METHODS: A retrospective analysis of all adults hospitalized with MASLD or metabolic dysfunction-associated steatohepatitis (MASH) with/with …
21,523 results
You have reached the last available page of results. Please see the User Guide for more information.